Five-year consolidated data
| 2016 | 2017 | 2018 | 2019 | 2020 |
|
| (Restated)1 |
|
|
|
CHF 1,000 |
|
|
|
|
|
Statement of profit or loss |
|
|
|
|
|
Sales | 506,227 | 548,559 | 593,795 | 636,819 | 730,879 |
EBITDA | 89,031 | 104,625 | 110,322 | 122,761 | 159,106 |
Operating profit (EBIT) | 68,137 | 79,796 | 88,553 | 88,699 | 121,390 |
Financial result | (2,709) | (804) | (5,155) | (5,959) | (3,163) |
Income taxes | (10,886) | (13,062) | (12,702) | (9,571) | (14,542) |
Profit for the period | 54,542 | 65,930 | 70,696 | 73,169 | 103,685 |
|
|
|
|
|
|
Research and development, gross | (47,090) | (51,069) | (51,086) | (59,857) | (62,043) |
Personnel expenses | (174,217) | (187,451) | (197,320) | (220,254) | (259,640) |
Depreciation of property, plant and equipment | (6,750) | (6,969) | (7,699) | (8,786) | (9,472) |
Depreciation of right-of-use assets2 | – | – | – | (10,513) | (10,915) |
Amortization of intangible assets | (14,144) | (16,723) | (14,070) | (14,541) | (15,056) |
Impairment losses | – | (1,137) | – | – | (2,051) |
|
|
|
|
|
|
Balance sheet |
|
|
|
|
|
Current assets | 534,290 | 602,194 | 596,048 | 615,499 | 777,986 |
Non-current assets | 201,871 | 201,767 | 261,623 | 324,274 | 330,641 |
Total assets | 736,161 | 803,961 | 857,671 | 939,773 | 1,108,627 |
Current liabilities | 141,956 | 153,142 | 163,470 | 157,286 | 225,018 |
Non-current liabilities | 107,120 | 100,698 | 81,792 | 123,420 | 149,958 |
Total liabilities | 249,076 | 253,840 | 245,262 | 280,706 | 374,976 |
Shareholders' equity | 487,085 | 550,121 | 612,409 | 659,067 | 733,651 |
|
|
|
|
|
|
Statement of cash flows |
|
|
|
|
|
Cash inflows from operating activities | 118,801 | 99,428 | 92,702 | 98,804 | 208,335 |
Capital expenditure in property, plant and equipment and intangible assets | (14,322) | (19,641) | (26,193) | (23,937) | (41,288) |
Acquisition of DCPM/PMAS3 | – | – | – | (20,846) | – |
Acquisition of NuGEN Technologies, Inc.3 | – | – | (43,805) | – | – |
Acquisition of Pulssar Technologies S.A.S.3 | – | (2,895) | – | – | – |
Acquisition of SPEware Group3 | (40,390) | – | (4,546) | (4,200) | – |
Dividends paid | (20,122) | (20,315) | (23,462) | (24,835) | (26,242) |
|
|
|
|
|
|
Other information |
|
|
|
|
|
Number of employees (end of period) | 1,447 | 1,482 | 1,662 | 1,932 | 2,050 |
Number of employees (average) | 1,368 | 1,469 | 1,562 | 1,818 | 1,984 |
|
|
|
|
|
|
Research and development in % of sales | 9.3% | 9.3% | 8.6% | 9.4% | 8.5% |
Sales per employee | 370 | 373 | 380 | 350 | 368 |
|
|
|
|
|
|
Information per share |
|
|
|
|
|
Basic earnings per share (CHF) | 4.74 | 5.67 | 6.02 | 6.18 | 8.69 |
Gross dividend (CHF)4 | 1.75 | 2.00 | 2.10 | 1.10 | 1.155 |
Payout from statutory capital contribution reserve (CHF)4 | 0.00 | 0.00 | 0.00 | 1.10 | 1.155 |
Total payout (CHF)4 | 1.75 | 2.00 | 2.10 | 2.20 | 2.305 |
Total payout ratio | 36.9% | 35.3% | 34.9% | 35.6% | 26.5% |
- Restated due to introduction of IFRS 15
- IFRS 16 introduced in 2019 (modified retrospective method)
- Net of cash acquired
- Payment is made in following year
- Proposal to the Annual General Meeting of Shareholders on April 13, 2021
Follow Tecan